CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Enhancing tumor-infiltrating T cells with an exclusive fuel source.
Enhancing tumor-infiltrating T cells with an exclusive fuel source.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
实体瘤具有免疫抑制性微环境,可通过大量消耗葡萄糖抑制TIL(肿瘤浸润淋巴细胞)。我们试图为 TIL 提供专属燃料来源,以恢复其功能。纤维素的组成二糖纤维二糖含有 β-1,4 糖苷键,动物(及其肿瘤)无法水解该键,但微生物已进化出可将纤维二糖分解为可利用葡萄糖的酶。我们使小鼠 T 细胞和人 CAR-T 细胞表达两种蛋白,从而能够摄取并水解纤维二糖;结果显示,在缺乏葡萄糖时补充纤维二糖可恢复关键抗肿瘤 T 细胞功能,包括存活、增殖、细胞因子生成和细胞毒性杀伤。能够利用纤维二糖的工程化 T 细胞可抑制小鼠肿瘤生长并延长生存。赋予细胞对天然二糖的专属利用能力,为增强癌症免疫疗法提供了新工具。该方法还可用于研究多种细胞类型、生物过程和疾病中的葡萄糖代谢问题。
Solid tumors harbor immunosuppressive microenvironments that inhibit tumor-infiltrating lymphocytes (TILs) through the voracious consumption of glucose.
We sought to restore TIL function by providing them with an exclusive fuel source. The glucose disaccharide cellobiose, which is the building block of cellulose, contains a -1,4-glycosidic bond that that animals (or their tumors) cannot hydrolyze, but microbes have evolved enzymes to catabolize cellobiose into useful glucose.
We equipped mouse T cells and human CAR-T cells with two proteins enabling import and hydrolysis of cellobiose and demonstrated that cellobiose supplementation during glucose withdrawal restores key anti-tumor T-cell functions: viability, proliferation, cytokine production, and cytotoxic killing.
Engineered T cells offered cellobiose suppress murine tumor growth and prolong survival. Offering exclusive access to a natural disaccharide is a new tool that augments cancer immunotherapies. This approach could be used to answer questions about glucose metabolism across many cell types, biological processes, and diseases.
MEMBER ACCOUNT
登录成功会直接打开下一页。